文献速递肺栓塞与肺血管病

镰状细胞病相关毛细血管前肺动脉高压的临床表型与结局

Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease.
PubMed 文献 · Eur Respir J · 2019-12-04

本研究基于法国肺动脉高压注册中心,回顾性分析58例镰状细胞病相关毛细血管前肺动脉高压患者,按基因型分为SS/S-β0地中海贫血组和SC组。结果显示SC患者肺灌注扫描节段性缺损更常见(85% vs 9%),SS/S-β0组6分钟步行距离和肺血管阻力更低。总体1、3、5年生存率分别为91%、80%、60%,基因型不影响预后。

要点

  • 镰状细胞病相关毛细血管前肺动脉高压预后差,5年生存率仅60%。
  • SC基因型患者肺灌注扫描节段性缺损更常见(85% vs 9%)。
  • 基因型不影响生存预后,但血栓性病变是重要组分。

核心结论

  • 镰状细胞病相关毛细血管前肺动脉高压患者预后差,5年生存率60%。
  • 血栓性病变似乎是镰状细胞病相关肺动脉高压的主要成分,在SC患者中更常见。
  • 基因型对预后无影响。

研究设计与样本

  • 全国多中心回顾性研究,纳入法国肺动脉高压注册中心所有镰状细胞病相关毛细血管前肺动脉高压患者。
  • 共纳入58例连续患者,其中41例为SS型,3例为S-β0地中海贫血型,14例为SC型。

主要发现

  • 与SC患者相比,SS/S-β0地中海贫血患者6分钟步行距离更低(p=0.01),肺血管阻力更低(p=0.04)。
  • 肺灌注扫描显示不匹配节段性缺损在SC患者中占85%,在SS/S-β0地中海贫血患者中占9%。
  • 50%的SS/S-β0地中海贫血患者存在无节段性缺损的异质性肺灌注。
  • 诊断肺动脉高压后,31例(53%)接受肺动脉高压批准药物治疗,23例(40%)开始慢性红细胞置换。
  • 4例因慢性血栓栓塞性肺动脉高压接受肺动脉内膜剥脱术(n=1)或球囊肺动脉成形术(n=3)。

临床怎么用

  • 对镰状细胞病患者应警惕毛细血管前肺动脉高压,尤其SC基因型者血栓性病变可能更突出。
  • 肺灌注扫描有助于识别SC患者中的节段性缺损,指导慢性血栓栓塞性肺动脉高压的评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE: Precapillary pulmonary hypertension (PH) is a devastating complication of sickle cell disease (SCD). Little is known about the influence of the SCD genotype on PH characteristics. OBJECTIVES: To describe clinical phenotypes and outcomes of precapillary PH due to SCD according to disease genotype. METHODS: A nationwide multicentre retrospective study including all patients with SCD-related precapillary PH from the French PH Registry was conducted. Clinical characteristics and outcomes according to SCD genotype were analysed. RESULTS: 58 consecutive SCD patients with precapillary PH were identified, of whom 41 had homozygous for haemoglobin S (SS) SCD, three had S-β0 thalassaemia (S-β0 thal) and 14 had haemoglobin SC disease (SC). Compared to SC patients, SS/S-β0 thal patients were characterised by lower 6-min walk distance (p=0.01) and lower pulmonary vascular resistance (p=0.04). Mismatched segmental perfusion defects on lung scintigraphy were detected in 85% of SC patients and 9% of SS/S-β0 thal patients, respectively, and 50% of SS/S-β0 thal patients had heterogeneous lung perfusion without segmental defects. After PH diagnosis, 31 patients (53%) received medical therapies approved for pulmonary arterial hypertension, and chronic red blood cell exchange was initiated in 23 patients (40%). Four patients were managed for chronic thromboembolic PH by pulmonary endarterectomy (n=1) or balloon pulmonary angioplasty (n=3). Overall survival was 91%, 80% and 60% at 1, 3 and 5 years, respectively, without influence of genotype on prognosis. CONCLUSIONS: Patients with precapillary PH related to SCD have a poor prognosis. Thrombotic lesions appear as a major component of PH related to SCD, more frequently in SC patients.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Savale L, Habibi A, Lionnet F, et al. Clinical phenotypes and outcomes of precapillary pulmonary hypertension of sickle cell disease. Eur Respir J. 2019. PMID: 31537700. doi:10.1183/13993003.00585-2019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。